1. Home
  2. IR vs RMD Comparison

IR vs RMD Comparison

Compare IR & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingersoll Rand Inc.

IR

Ingersoll Rand Inc.

SELL

Current Price

$77.76

Market Cap

32.6B

Sector

Industrials

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

SELL

Current Price

$238.42

Market Cap

34.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IR
RMD
Founded
1859
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.6B
34.0B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
IR
RMD
Price
$77.76
$238.42
Analyst Decision
Buy
Buy
Analyst Count
14
20
Target Price
$94.71
★ $251.99
AVG Volume (30 Days)
★ 4.2M
967.2K
Earning Date
10-29-2026
10-29-2026
Dividend Yield
0.10%
★ 1.09%
EPS Growth
N/A
★ 9.67
EPS
1.15
★ 10.43
Revenue
$2,375,400,000.00
★ $2,957,013,000.00
Revenue This Year
$6.09
$2.59
Revenue Next Year
$4.95
$6.92
P/E Ratio
$67.66
★ $23.25
Revenue Growth
★ 22.48
13.44
52 Week Low
$68.07
$180.27
52 Week High
$100.96
$277.67

Technical Indicators

Market Signals
Indicator
IR
RMD
Relative Strength Index (RSI) 51.94 66.40
Support Level $75.10 $217.41
Resistance Level $84.36 $242.40
Average True Range (ATR) 2.01 4.63
MACD 0.24 1.94
Stochastic Oscillator 52.61 85.93

Price Performance

Historical Comparison
IR
RMD

About IR Ingersoll Rand Inc.

Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.7 billion in revenue in 2025.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: